REPEAT · Checked.be

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of REPEAT is 0.2% (very low). The 2025 annual accounts show equity of €12k and a net result of €-914. Its solvency ranks better than 54% of 6601 sector peers (fiscal year 2024). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 2 annual accounts.

Filing behaviour

From the deposit records, complete market-wide

Filed after the deadline

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-08-2026, 28 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.

The next deadline is still running

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.

How we compute the deadline

The year end is derived from 2 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2025, that is 31-07-2026.

Deadline per financial year

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	28-08-2026	28 d late	2026-00467499
31-12-2024	31-07-2025	30-08-2025	30 d late	2025-00454681

Source: the National Bank's deposit records, as we have ingested them. NOTE: our copy has a gap across June to August 2026, missing roughly 220,000 deposits; for July we hold 15,605 of about 137,000 expected. A year whose deadline falls in that window shows as not confirmed, not as not filed. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals

Young company

Founded in 2023, under 3 years, statistically higher risk.

No legal incidents

No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone

0.2% Very low

0%0,5%1,5%4%10%≥25%

Lower-failure-rate sector −Young company +Annual accounts: weaker financial profile +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (micro schema)

EBIT marginNot published (micro schema)

Net result€-914

Working capital€7k-13.9%

CSV export

Annual accounts & ratios

Source: NBB · 2025

Annual accounts filed on 28-08-2026 with the NBB · fiscal year 2025 · micro

Operating resultNet result

Sector comparison

Fiscal year 2024 · NACE 86, Human health · compared within the same schema type (micro schema)

Metric	This company	Sector median	Position in the sector
Solvency	69.8%	66.7%	better than 54% of 6601 sector peers
Net result	€10k	€46k	better than 19% of 6595 sector peers
Equity	€13k	€79k	better than 14% of 6601 sector peers
Gross operating margin	€15k	€78k	better than 12% of 6603 sector peers
Total assets	€18k	€154k	better than 5% of 6604 sector peers

Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.

EBITDA

€1k

-91.0% 24-25

Net profit

€-914

- 24-25

Cash flow

€-25

- 24-25

Total assets

€18k

-2.1% 24-25

Equity

€12k

-7.1% 24-25

Working capital

€7k

-13.9% 24-25

Income taxes

€694

-80.3% 24-25

Debt

€6k

+9.5% 24-25

Show 8 other metrics

Debt ≤ 1y

€6k

+5.6% 24-25

Current ratio

2.29

-11.3% 24-25

Quick ratio

2.29

-11.3% 24-25

Solvency

66.2%

-5.1% 24-25

Debt / equity

0.51

+17.9% 24-25

ROE

-7.7%

- 24-25

ROA

-5.1%

- 24-25

Interest coverage

1.99

-91.7% 24-25

Figures by fiscal year

Highlight YoY changes (±10%)

Fiscal year	2025
Deposit	micro
Revenue	-
EBITDA	€1k
Net profit	€-914
Cash flow	€-25
Staff costs	-
Income taxes	€694
Dividends	-
Total assets	€18k
Equity	€12k
Debt	€6k
of which ≤ 1y	€6k
of which > 1y	-
Working capital	€7k
Employees (FTE)	-

Ratios (computed)

	2025
Current ratio	2.29
Quick ratio	2.29
Working capital ratio	40.4%
Solvency	66.2%
Debt / equity	0.51
Long-term debt ratio	-
Interest coverage	1.99
Gross margin	-
Net margin	-
ROA	-5.1%
ROE	-7.7%
EBITDA margin	-
Days sales outstanding	-
Days payable outstanding	-
Inventory turnover	-
Days inventory (DSI)	-

Balance-sheet composition 2025

Assets

Fixed assets €5k · 28.2% Current assets €13k · 71.8%

Equity & liabilities

Equity €12k · 66.2% Debt €6k · 33.8%

Full annual accounts (21 line items)

Filed balance sheet and income statement, exactly as deposited with the NBB.

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€18k
Fixed assets	21/28	€5k
Tangible fixed assets	22/27	€3k
Financial fixed assets	28	€3k
Current assets	29/58	€13k
Amounts receivable within one year	40/41	€8k
Cash & bank	54/58	€3k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€18k
Equity	10/15	€12k
Contributions / capital	10/11	€3k
Reserves	13	€9k
Amounts payable	17/49	€6k
Amounts payable within one year	42/48	€6k
Trade debts payable within one year	44	€1k
Income statement
Gross operating margin	9900	€2k
Operating result	9901	€460
Financial charges	65	€679
Result before taxes	9903	€-220
Income taxes	67/77	€694
Net result for the period	9904	€-914
Result to be appropriated	9905	€-914

This table shows the latest fiscal year. 1 prior year, with figures and ratios, belongs to a paid plan. See plans →

Ratios computed by Checked.

Health barometer

FY 2025 · computed

65 / 100 Healthy

050100

Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.

See plans →

Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.

Structure & network

Locations & real estate

Registered office

from the Crossroads Bank

Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Grotehondstraat 322018 Antwerpen

Establishment units

1 location

REPEAT

Grotehondstraat 32, 2018 AntwerpenOverige detailhandel in voedingsmiddelen in gespecialiseerde winkels, n.e.g.

since 20232.354.355.294

Physical sites registered in the Crossroads Bank for Enterprises (CBE).

Parcels1

Ground area238 m²

Buildings1

Building footprint151 m²

Volume (LiDAR)1,834 m³

Tallest building17.2 m · ±5 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)

Parcel (capakey)	Region	Area	Buildings	Height / fl.
11806F1277/00Y005	Flanders	238 m²	1 · 151 m²	17.2 m · 5 fl.

Methodology

via registered seat: 1

1 of 1 parcel with an exact address match; the rest are indicative.

Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgian State Gazette · acts

No structured acts for this company yet

That means one of two things: the company has published no company deeds, or its deeds are still queued for reading. The insolvency signals above come from a separate source; the KBO register is the second source and appears as the legal situation on this page.